Mephentermine Dependence: Emerging Trend of Substance Abuse and its Challenges


Prabhdeep Singh
Balwant S. Sidhu
Rajnish Raj
Neeraj Mittal


Dependence on Mephentermine, a widely used sympathomimetic pressor agent, is so far not extensively reported. In current report, we describe a male patient consuming extraordinary high amount of Mephentermine who developed psychosis which was successfully treated but relapsed after 5 months. In this background we also tried to highlight this trend of shift from more traditional drugs to new synthetic ones and look into the magnitude of the problem and challenges that lie ahead of us.


How to Cite
Singh, P., Sidhu, B. S., Raj, R., & Mittal, N. (2019). Mephentermine Dependence: Emerging Trend of Substance Abuse and its Challenges. International Journal of Medical and Dental Sciences, 1715–1717.


  1. Gupta KK, Singh A, Singh G, Aggarwal S. Uncommon drug abuse: An anaesthetist dilemma. Anaesthesia Essays and Researches. 2015; 9(1):116–17.
  2. Gehlawat P, Singh P, Gupta R, Arya S. Mephentermine dependence with psychosis. Gen Hosp Psychiatry. 2013; 35(6):681.e9–10. PMid:23759255
  3. Sawant NS, Vispute CD. Mephentermine dependence with induced psychosis. German J Psychiatry. 2012; 15(2): 69–71.
  4. De Sousa HF, De Oliveira MF, Lima MCD, De Oliveira JRD. Mephentermine dependence without psychosis: A Brazilian case report. Addiction 2010; 105(6):1129–30. PMid:20456293
  5. Mattoo SK, Parakh P. Mephentermine dependence: An emerging challenge. CNS Neuroscience and Therapeutics. 2012; 18:509–10. PMid:22672305
  6. Oliveira MF, De Sousa HF, Lima MCD, Oliveira JRM de. Mephentermine: rediscovering its biology and use, misuse and their implications. Rev Bras Psiquiatria Sao Paulo, Brazil. 1999; 33(1):98–9.

Most read articles by the same author(s)